AGECHEM VENTURE FUND
The AgeChem Fund L.P. currently has $65 million under management and is seeking to invest in companies developing therapeutics targeting age-related diseases. Principally, AgeChem wishes to build a portfolio of Companies developing novel therapeutics to treat metabolic disorders (e.g. diabetes, obesity), cardiovascular diseases, cancers, diseases of the central nervous system (e.g. Alzheimer, Parkinson, insomnia), inflammatory diseases (e.g. rheumatoid arthritis, psoriasis), ophthalmic diseases and numerous other age-related diseases.
AGECHEM VENTURE FUND
Founded:
2006-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Apache PHP
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2014-05-15 | Sorbent Therapeutics | AgeChem Venture Fund investment in Series D - Sorbent Therapeutics | 6.5 M USD |
| 2013-11-06 | Aerpio Pharmaceuticals | AgeChem Venture Fund investment in Series A - Aerpio Pharmaceuticals | 36 M USD |
| 2013-06-04 | Akebia Therapeutics | AgeChem Venture Fund investment in Series C - Akebia Therapeutics | 41 M USD |
| 2012-11-02 | Alethia BioTherapeutics | AgeChem Venture Fund investment in Series B - Alethia BioTherapeutics | 4.7 M USD |
| 2011-09-27 | Medicago | AgeChem Venture Fund investment in Post-IPO Equity - Medicago | 25 M CAD |
| 2011-06-30 | Sorbent Therapeutics | AgeChem Venture Fund investment in Series B - Sorbent Therapeutics | 36 M USD |
| 2011-04-26 | Akebia Therapeutics | AgeChem Venture Fund investment in Series B - Akebia Therapeutics | 22 M USD |
| 2011-02-11 | Conatus Pharmaceuticals | AgeChem Venture Fund investment in Series B - Conatus Pharmaceuticals | 20 M USD |
| 2010-09-13 | Sorbent Therapeutics | AgeChem Venture Fund investment in Series B - Sorbent Therapeutics | 21.8 M USD |
| 2010-09-07 | Alethia BioTherapeutics | AgeChem Venture Fund investment in Series A - Alethia BioTherapeutics | 9.2 M USD |